In the news ... 2008
FOR IMMEDIATE RELEASE:
Project Inform to Honor Martin Delaney —
Key Architect of the Response to HIV/AIDS
June 2, 2008
SAN FRANCISCO, CA — Project Inform announced
today that it will honor Martin Delaney for his 23 years of pivotal
leadership in the fight against HIV/AIDS on June 19 in San Francisco.
The event will be held on the evening of June 19 at the Green Room
in the San Francisco War Memorial Building.
“On the great and tearful day that the complete history
of the AIDS tragedy is finally written, there is no question that
Marty Delaney will be described for his enormous contribution to
the effort to identify and make accessible effective treatments
and a cure for HIV infection,” said Dana Van Gorder, Executive
Director of Project Inform. “The June 19 event represents
a great opportunity for the community to recognize Marty for his
role in advancing HIV treatment, as well as in educating hundreds
of thousands of people living with HIV about how and when to best
address HIV infection.”
Delaney is one of the principal architects of an enlightened response
to the HIV/AIDS pandemic, and has preserved and improved the quality
of life for countless individuals. He is the Founder of Project
Inform, one of the nation’s most respected non-profit agencies
working in HIV/AIDS. Marty helped to lead Project Inform from its
inception in 1985 until January of 2007. He has been a constructive
critic of federal, academic, and industry AIDS research efforts,
and a key figure in helping to bring effective HIV treatments to
market. He is a leader of the movement to accelerate FDA approval
of promising drugs and was a key player in the development of today’s
widely used Accelerated Approval regulations and Parallel Track
system for providing experimental drugs to seriously ill people
preceding formal approval by the FDA. He was one of the founders
of the community-based HIV research movement and, through Project
Inform, led the way to an unprecedented level of HIV treatment
education becoming available to patients and medical providers.
Over the last 23 years, Delaney has spoken before more community,
government, and industry groups on AIDS treatment and research
issues than any other activist or political figure. He has served
on many AIDS related local and national boards and prominent government
advisory groups. He currently leads the Fair Pricing Coalition,
which presses industry to assure that HIV medications are accessible
and he is the Chair of the Board of the Foundation for AIDS and
Immune Research, which makes grants to support promising HIV-related
research.
Information about the June 19 event honoring Delaney is available
by calling 415-558-8669 x 211 or emailing .